Showing results (1-10 of 308) with videos related to
Sort By:
Pageof 31
Seminars in Liver Disease|May 4, 2011
Deciphering the genetic predisposition to primary sclerosing cholangitisTom H Karlsen, Arthur KaserJournal of Autoimmunity|August 13, 2013
Novel insights into autoimmune liver diseases provided by genome-wide association studiesGeorge F Mells, Arthur Kaser, Tom H KarlsenDigestive Diseases (Basel, Switzerland)|October 19, 2012
A lecture on the genetics of primary sclerosing cholangitisTom H KarlsenGut|March 24, 2021
Activation of the GPR35 pathway drives angiogenesis in the tumour microenvironmentEster Pagano, Joshua E Elias, Georg Schneditz, et al.Best Practice & Research. Clinical Gastroenterology|June 11, 2014
Not all monoclonals are created equal - lessons from failed drug trials in Crohn's diseaseArthur KaserCommunications Biology|March 23, 2025
GPR35 prevents osmotic stress induced cell damageJoshua E Elias, Mekdes Debela, Gavin W Sewell, et al.Nature Reviews. Gastroenterology & Hepatology|March 16, 2017
Genetics of primary sclerosing cholangitis and pathophysiological implicationsXiaojun Jiang, Tom H KarlsenExpert Opinion on Therapeutic Targets|April 16, 2008
Novel therapeutic targets in the treatment of IBDArthur Kaser, Herbert TilgExpert Opinion on Biological Therapy|October 22, 2002
Antitumour necrosis factor therapy in Crohn's diseaseHerbert Tilg, Arthur KaserExpert Opinion on Biological Therapy|April 23, 2004
Type I interferons and their therapeutic role in Th2-regulated inflammatory disordersHerbert Tilg, Arthur KaserPageof 31